Background {#Sec1}
==========

Despite syphilis being a curable sexually transmitted infection (STI) with proven diagnostics and known treatment and prevention strategies, it is estimated that 6 million incident syphilis cases occur worldwide annually \[[@CR1]\]. In South America and Peru, research indicates that syphilis is hyperendemic among men who have sex with men (MSM) and male-to-female transgender women (transwomen) \[[@CR2]--[@CR4]\]. In 2008, the prevalence of syphilis infection, verified by laboratory testing, was estimated to be 28.9% among MSM in Lima, Peru \[[@CR5]\].

As evidenced by persistent incident syphilis infection among MSM and transwomen in Peru, current screening and management strategies are inadequate \[[@CR6]\]. Syphilis is associated with increased risk of HIV infection, therefore quality prevention and treatment measures could have the added benefit of mitigating HIV acquisition and transmission \[[@CR7]\]. Indeed, more research is needed to characterize determinants of syphilis among groups who are at highest risk. To better address ongoing endemic infections, these data will be presented to the Ministry of Health of Peru with recommendations to guide HIV and syphilis infection control strategies in Peru \[[@CR8]\]. In this manuscript, we report baseline characteristics and behaviors associated with incidence of recently acquired syphilis infection using quality laboratory testing and results from socio-demographic and behavioral surveys among a clinic-based observational cohort of MSM and transwomen in Lima, Peru.

Methods {#Sec2}
=======

Study population and consent to publish {#Sec3}
---------------------------------------

Participants were recruited at two clinics that serve MSM and transwomen---Epicentro, located in the Barranco district, and Alberto Barton Health Center, located in the Callao district. Epicentro is a community-based non-governmental organization for MSM and transwomen that provides HIV/STI testing, medical care, and community activities. The Alberto Barton Health Center is a government run HIV and STI clinic that provides testing and medical care specifically for MSM and transwomen.

To recruit a study cohort of MSM and transwomen who were at increased risk of syphilis infection, we developed inclusion criteria by adapting risk score protocols from other scientific fields used for identification of suitable participants \[[@CR8], [@CR9]\]. Eligible participants were: MSM or transwomen, aged ≥18 years, seeking testing and/or care for human immunodeficiency virus (HIV) or an STI, willing to return for follow-up appointments every 3 months over 2 years (eight follow-up appointments in total), and have at least three of the following traits: (i) a positive syphilis rapid treponemal test; (ii) a reactive HIV rapid test; (iii) 5 or more years of sexual activity; (iv) five or more sex partners in the past 3 months; (v) diagnosis of an STI in the last 6 months; (vi) genital ulceration; or (vii) five or more episodes of condomless anal intercourse in the past 6 months.

Study procedures, risks and benefits of participating in the study, the option to discontinue study participation at any time, and a means to contact investigators and study coordinators were provided to participants. Written informed consent was obtained prior to study initiation. Participants were reimbursed approximately \$5 in local currency for transportation. Condoms, lubricants, and all study related testing and clinical care were provided at no cost to participants.

Study procedures {#Sec4}
----------------

Demographic, gender, and health and sexual behavior data were collected by trained study staff using computer-assisted structured interviews. Demographic characteristics included: date of birth, area of residence, education, income, and living arrangement. Gender was self-reported. Health history and behavior included: any past syphilis infections, antibiotic use, and knowledge of HIV. Locations of recent (in the past three months) sexual encounters, use of alcohol or drugs during sex, payment for sex, gender of sex partners, number of sex partners, types of relationships with sex partners, and role during sex were also recorded. Role during anal sex was defined as insertive, receptive, or versatile (both insertive and receptive). Surveys assessed whether participants had received a prior diagnosis of HIV infection by a health care provider and if participants with a diagnosis of HIV infection were using antiretroviral therapy (ART). Alcohol use was assessed using the WHO Alcohol Use Disorders Identification Test and scores were dichotomized with ≥8 indicating an alcohol use disorder \[[@CR10]\].

A trained health care provider examined participants after they completed the survey. Participants provided biological samples for diagnostic testing.

Laboratory testing {#Sec5}
------------------

Rapid point-of-care tests were used to assess participants for syphilis (Alere Determine™ Syphilis TP, Alere Inc., Waltham, MA, USA) and HIV infection (Alere Determine™ HIV 1/2, Alere Inc., Waltham, MA, USA). All participants were assessed for syphilis with rapid plasma reagin (RPR) (BD Macro-Vue™ RPR Card Test Kit, Beckton Dickinson, Franklin Lakes, NJ) and Treponema Pallidum Particle Agglutination (TPPA) tests (Serodia, Fujirebio Diagnostics Inc., Tokyo, Japan) using a cutoff value of ≥1:80. The highest reactive RPR titer was reported and recorded. Recently acquired syphilis infection was defined as a RPR titer ≥1:16 and a positive TPPA test. Prior syphilis was defined as RPR titers from 1:1--1:8 and a positive TPPA test. All participants were tested with HIV Ag/Ab EIA 4th generation sera tests (Genscreen ULTRA HIV Ag-Ab, Bio-Rad, Hercules, CA). Confirmation Western Blot tests were conducted (NEW LAV BLOT I, Bio-Rad, France) on all specimens with positive rapid HIV testing results. Participants with confirmed HIV infection were referred to the Peruvian National HIV Treatment Program \[[@CR6]\].

Confirmation testing for syphilis and HIV infection, as well as testing for *Neisseria gonorrhoeae* (NG) and *Chlamydia trachomatis* (CT) infections, was performed at the Universidad Peruana Cayetano Heredia Sexual Health Laboratory. Clinician-collected pharyngeal specimens and self-collected anal swabs were tested for CT and NG infection using a transcription mediated amplification assay (Aptima Combo 2 Assay, Hologic, Inc., San Diego, USA). Urethral testing for STIs was not conducted in this study because the prevalence of asymptomatic urethral STIs in this population was very low in prior studies \[[@CR11], [@CR12]\].

Rapid test results were available on the day of testing. All other test results were delivered 2 weeks post-visit. Patients received appropriate post-test counseling, treatment (when indicated), and were requested to inform their sex partners about any STI, following Peruvian Ministry of Health protocol \[[@CR6]\]. STI treatment was offered on-site according to Centers for Disease Control and Prevention and Peruvian national guidelines \[[@CR13]\].

Statistical analyses {#Sec6}
--------------------

StataSE 14.1 (College Station, TX) was used to perform descriptive statistics for inclusion criteria, characteristics of the study cohort, and prevalence of infection of the cross-sectional data for MSM and transwomen. Latent class analysis was used to assess whether any identifiable subgroups were present in the cohort \[[@CR14]\]. Bivariate and multivariate analyses explored associations with recently acquired syphilis infection within the total cohort. To increase the sample size, we did not separate MSM and transwomen in those analyses. Individuals with recently acquired syphilis infection were compared to participants with non-reactive RPR tests. Participants with laboratory testing indicating prior syphilis (RPR titers from 1:1--1:8) were excluded from regression analyses. Characteristics of participants with recently acquired syphilis infection were compared to characteristics of participants with no history of syphilis using Poisson regression to compute prevalence ratios with 95% confidence intervals (CI). The multivariate model included all statistically significant (*p*-value of \<0.05) variables in the bivariate analysis.

Ethics, consent, and permissions {#Sec7}
--------------------------------

The Institutional Review Board at Universidad Peruana Cayetano Heredia and Alberto Barton Health Center provided ethical approval and oversight of the study under reference number SIDISI 59996. The University of California Los Angeles institutional review board determined that analysis of de-identified data was exempt from human subjects\' considerations.

Results {#Sec8}
=======

From May 2013 to May 2014, 401 participants, 312 MSM and 89 transwomen, were recruited into the PICASSO cohort in Lima, Peru. The median ages of MSM and transwomen were 29.0 and 32.5 years (interquartile ranges \[IQR\]: 23.3, 37.4 and 27.2, 39.5, respectively). Among participants, 27.9% of MSM and 76.5% of transwomen earned less than minimum wage (approximately \$250 USD per month; Table [1](#Tab1){ref-type="table"}). In survey results collected from participants prior to laboratory testing, 35.6% of MSM and 39.3% of transwomen reported a prior diagnosis of syphilis and 24.1% of MSM and 27.6% of transwomen reported a prior diagnosis of HIV infection. Among participants with a self-reported prior diagnosis of HIV infection, 54.8% of MSM and 52.4% of transwomen reported that they were not using ART (Table [1](#Tab1){ref-type="table"}). MSM reported that during anal sex, 50.3% were a versatile partner (i.e. having receptive and insertive anal sex), 21.8% were a receptive partner, and 27.9% were an insertive partner. Transwomen reported that during anal sex, 30.3% were a versatile partner, 67.4% were a receptive partner, and 2.3% were an insertive partner. The median number of recent male or transwomen sex partners reported by MSM and transwomen was 4 (IQR: 2, 7) and 15 (IQR: 5, 40), respectively.Table 1Baseline characteristics of men who have sex with men and male-to-female transgender participants of the PICASSO study, Lima, Peru, 2013--2014CharacteristicMSMTranswomenn (*N* = 312) (%)n (*N* = 89) (%)*Survey* Age median years (Interquartile range \[IQR\])29.0 (23.3, 37.4)32.5 (27.2, 39.5) Income less than living wage^a^87 (27.9)62 (76.5) Education  Primary school or less7 (2.2)8 (9.0)  Secondary school or less111 (35.6)65 (73.0)  Vocational school graduate69 (22.1)11 (12.4)  University student90 (28.9)3 (3.4)  University graduate or higher40 (11.2)2 (2.3) Work  Full time157 (50.3)33 (37.1)  Part time41 (13.1)23 (25.8)  Odd jobs46 (14.7)26 (29.2)  Unemployed or does not work68 (21.8)7 (7.9) Use of antibiotics in the last 3 months123 (39.4)37 (41.6) Use of un-prescribed injections in the last 3 months93 (29.8)27 (30.3) Comorbidities (by self-report in the survey):  Prior diagnosis of syphilis111 (35.6)35 (39.3)  Prior diagnosis of HIV62 (24.1)21 (27.6)   Not taking ART34/62 (54.8)11/21 (52.4)    Recent syphilis by laboratory testing8/34 (23.5)1/11 (9.1)    Diagnosis of STI in the last 6 months22/34 (64.7)5/11 (45.5) Primary role during anal sex  Insertive87 (27.9)2 (2.3)  Receptive68 (21.8)60 (67.4)  Versatile (e.g. both)157 (50.3)27 (30.3) Stable^b^ partner, last 3 months141 (45.2)47 (52.8) Sex with a male partner, last 3 months312 (100)81 (100) Median number of male partner(s), last 3 months (IQR)4 (2, 7)15 (5, 40) Sex with a female partner, last 3 months45 (14.4)1 (1.1) Alcohol use disorder (AUDIT score \> 8)139 (44.6)42 (47.2)  *Laboratory*  Syphilis infection   Recent syphilis (RPR ≥ 1:16)52 (16.8)6 (6.7)   Prior syphilis infection^c^ (RPR between 1:1--1:8)79 (25.3)45 (50.6)   No syphilis infection^d^157 (50.8)38 (42.7)  HIV infection94 (30.1)30 (33.7)  Total *Chlamydia trachomatis* (CT)57 (18.6)22 (24.7)   Anal CT43 (14.1)12 (13.5)   Pharyngeal CT14 (4.5)10 (11.2)  Total *Neisseria gonorrheae* (NG)44 (14.2)17 (19.1)   Anal NG26 (8.4)10 (11.2)   Pharyngeal NG18 (5.8)7 (7.9)  Co-infections with recent syphilis (*n* = 58, MSM \[*N* = 52\]; Transwomen \[*N* = 6\])   HIV23 (44.2)4 (66.7)   Total CT21 (40.4)0 (0)   Anal CT17 (32.7)0 (0)   Pharyngeal CT4 (7.7)0 (0)   Total NG10 (19.2)1 (16.7)   Anal NG6 (11.5)1 (16.7)   Pharyngeal NG4 (7.7)0 (0)Human immunodeficiency virus (HIV); antiretroviral therapy (ART); Rapid plasma reagin (RPR); *Treponema Pallidum* Particle Agglutination (TPPA); *Chlamydia trachomatis* (CT); *Neisseria gonorrheae* (NG); and sexually transmitted infection (STI)^a^Living wage was approximately \$250 USD per month in 2013--2014^b^The participant self-identified that they had a stable sexual partner^c^TPPA positive individuals that did not meet criteria for recently acquired syphilis infection^d^RPR-negative and TPPA-negative individuals

Among our participants with a prior diagnosis of HIV, 54.8% of MSM and 52.4% of transwomen reported that they were not on ART (Table [1](#Tab1){ref-type="table"}). Among HIV infected MSM not taking ART, 23.5% had recently acquired syphilis infection detected by laboratory testing and 64.7% had a diagnosis of a STI in the last 6 months. Among HIV infected transwomen participants not taking ART, 9.1% had recently acquired syphilis infection detected by laboratory testing and 45.5% had a diagnosis of a STI in the last 6 months.

Of the inclusion criteria needed for inclusion, the majority of the cohort reported over 5 years of sexual activity, more than five events of condomless anal sex in the past 6 months, and more than five sex partners in the past 3 months (Table [2](#Tab2){ref-type="table"}).Table 2Frequency of inclusion criteria among men who have sex with men and male-to-female transgender participants of the PICASSO cohort, Lima, Peru, 2013--2014 (*n* = 401)Inclusion CriteriaMSMTranswomenn (*N* = 312) (%)n (*N* = 89) (%)MSM or transwomen312 (100)89 (100)Age greater or equal to 18 years312 (100)89 (100)Seeking care for HIV or STIs312 (100)89 (100)Willing to return for eight follow up visits over 2 years312 (100)89 (100)*Meet at least three of the following criteria:*1. More than 5 years of sexual activity289 (92.6)87 (98.0)2. More than five occurrences of condomless anal sex in the past 6 months225 (72.1)73 (82.0)3. More than five sex partners in the past 3 months197 (63.1)81 (91.0)4. A positive syphilis test in the past 2 years128 (41.0)40 (45.0)5. Any STI diagnosis within the past 6 months145 (46.5)22 (24.7)6. Any syndromic ulcer-related STI at the time of screening138 (44.2)23 (25.8)7. Diagnosed with HIV infection62 (19.9)24 (27.0)Men who has sex with men (MSM); Transwomen (male-to-female transwomen); Human immunodeficiency virus (HIV); Sexually transmitted infection (STI)

Prevalence of recently acquired syphilis infection and other STIs {#Sec9}
-----------------------------------------------------------------

Laboratory testing showed that the baseline prevalence of recently acquired syphilis infection was 16.8% for MSM and 6.7% for transwomen participants (Table [1](#Tab1){ref-type="table"}). Among MSM, 30.1% were infected with HIV, 14.1% were infected with anal CT, 4.5% were infected with pharyngeal CT, 8.4% were infected with anal NG, and 5.8% were infected with pharyngeal NG. Among transwomen participants, 33.7% were infected with HIV, 13.5% were infected with anal CT, 11.2% were infected with pharyngeal CT, 11.2% were infected with anal NG, and 7.9% were infected with pharyngeal NG. Co-infection rates among the 52 MSM with recently acquired syphilis infection included: 44.2% with HIV, 40.4% with CT (32.7% was anal CT and 7.7% was pharyngeal CT), and 19.2% with NG (11.5% was anal NG and 7.7% was pharyngeal NG). Co-infection rates among the six transwomen participants with recently acquired syphilis infection included: 66.7% with HIV, 0% with CT, and 16.7% with NG (16.7% was anal NG).

Characteristics associated with recently acquired syphilis infection {#Sec10}
--------------------------------------------------------------------

In multivariable analysis of pooled MSM and transwomen data, recently acquired syphilis infection was independently associated with younger age (adjusted prevalence ratio \[aPR\] = 0.96, 95% CI = 0.93--0.99; Table [3](#Tab3){ref-type="table"}). Among behavioral characteristics, receptive role during anal sex (aPR = 2.56, 95% CI = 1.05--6.25) was independently associated with recently acquired syphilis infection. Among biological characteristics, self-reported prior HIV diagnosis (aPR = 1.70, 95% CI = 1.11--2.61), anal CT or NG infection (aPR = 1.69, 95% CI = 1.09--2.60), and self-reported prior syphilis diagnosis, which did not include infection detected during the study, (aPR = 3.53, 95% CI = 2.20--5.68) were independently associated with recently acquired syphilis infection. Latent class analysis did not identify any subgroups in our cohort with regard to our primary outcome variable, recently acquired syphilis infection.Table 3Associations between recently acquired syphilis infection and characteristics of PICASSO study participants, Lima, Peru, 2013--2014Baseline characteristicsRecently acquired syphilis infection prevalenceBivariate analysisMultivariate analysisn/N (%)Crude PR (95% CI)Adjusted PR (95% CI)Overall58/285 (20.4)Age, years**0.97 (0.94--0.99)0.96 (0.93--0.99)** 18--2522/98 (22.5) 26--3013/56 (23.2) 31--3513/50 (26.0) 36+10/81 (12.4)Number of recent male/transwomen sex partners (quartiles) 0--221/86 (24.4)Ref 3--518/84 (21.4)0.88 (0.50--1.53) 6--108/50 (16.0)0.66 (0.31--1.37) 11+11/65 (16.9)0.69 (0.36--1.34)Role during anal sex Insertive5/71 (7.0)RefRef Receptive22/85 (25.9)**3.68 (1.46--9.22)2.56 (1.05--6.25)** Versatile31/129 (24.0)**3.41 (1.39--8.40)**1.99 (0.82--4.85)Condomless anal sex with a male partner, last 3 months No14/70 (20.0)Ref Yes44/215 (20.5)1.02 (0.59--1.75)Condomless anal sex with stable male partners, last 3 months No21/97 (21.7)Ref Yes37/188 (19.7)0.91 (0.56--1.46)Any anal sex partner met over the Internet in last 3 months No34/182 (18.7)Ref Yes24/103 (23.3)1.25 (0.78--1.98)Any anal sex with an anonymous sex partner in last 3 months No30/140 (21.4)Ref Yes28/145 (19.3)0.90 (0.57--1.43)Any anal sex in a sex club in last 3 months No46/244 (18.9)Ref Yes12/41 (29.3)1.55 (0.90--2.67)HIV infection Negative31/206 (15.1)RefRef Known infected^a^20/50 (40.0)**2.66 (1.66--4.25)1.70 (1.11--2.61)** Newly diagnosed7/29 (24.1)1.60 (0.78--3.31)1.37 (0.72--2.60)Any anal CT or NG infection Negative38/229 (16.6)RefRef Positive20/56 (35.7)**2.15 (1.36--3.40)1.69 (1.09--2.60)**Previous syphilis diagnosis (per patient interview) No24/213 (11.3)RefRef Yes34/71 (47.9)**4.25 (2.71--6.66)3.53 (2.20--5.68)**Alcohol use disorder (AUDIT score ≥ 8) No32/151 (21.2)Ref Yes26/134 (19.4)0.92 (0.58--1.45)Transwomen (male-to-female transwomen); Human immunodeficiency virus (HIV); *Chlamydia trachomatis* (CT); and *Neisseria gonorrheae* (NG)^a^Self reported on baseline survey^b^Bolded text indicates a *p*-value \<0.05

Discussion {#Sec11}
==========

The PICASSO cohort study successfully recruited 401 at risk participants, 312 MSM and 89 transwomen, with a high baseline prevalence of recently acquired syphilis infection in Lima, Peru. Among participants, the prevalence of recently acquired syphilis infection was 16.8% among MSM and 6.7% among tranwomen and HIV infection was 30.1% among MSM and 33.7% among transwomen participants. Among participants with recently acquired syphilis infection, STI and HIV co-infection were high. We found that recently acquired syphilis infection was independently associated with younger age, receptive anal sex, rectal bacterial STIs, self-reported prior HIV diagnosis, and prior syphilis diagnosis.

A limited number of studies report syphilis data in Peru. A study conducted prior to the introduction of ART showed a decrease in recently acquired syphilis infection (defined as a VDRL or RPR titer ≥1:16) from 8.6 in 1996 to 3.4% in 2002 \[[@CR15]\]. Among MSM, two studies conducted after introduction of ART estimated the prevalence of recently acquired syphilis infection was 5.4 and 10.5% \[[@CR16], [@CR17]\]. Another study from 2012 reported that among HIV uninfected MSM and transwomen, 18% had positive serology for syphilis \[[@CR18]\]. Prior studies differ from our cohort because we sampled at-risk MSM and transwomen recruited from HIV/STI clinics in the post-ART era. Our cohort was thoroughly surveyed and tested and was found to have a high incidence of recently acquired syphilis infection.

Prior reports described independent associations between recently acquired syphilis infection and HIV infection, increased number of years of sexual activity, and condomless anal intercourse among MSM and transwomen \[[@CR16], [@CR19]\]. We found that recently acquired syphilis infection was independently associated with rectal bacterial STIs and self-reported HIV diagnosis.

We found that among participants with a prior diagnosis of HIV, the majority of MSM and transwomen were not on ART. Among HIV-infected MSM and transwomen participants not taking ART, many participants had a recently acquired syphilis infection detected by laboratory testing and about half of all participants had a diagnosis of any STI in the last 6 months. Those data imply that HIV-infected MSM and transwomen not on ART had recent sex with increased risk of HIV infection transmission \[[@CR20]\]. Improved management of HIV infection among MSM and transwomen is needed in Peru to prevent further spread of infection.

Our study has the following limitations. The clinic-based cohort was neither population-based nor randomly selected. We had limited statistical power to compare MSM versus transwomen in our study. Comparison analyses were conduced between MSM and transwomen in our cohort and showed no significant differences in identified risk factors. Additionally, latent class analysis was performed to ensure there were no identifiable subgroups in our cohort with regard to our primary outcome variable (i.e., recently acquired syphilis infection) \[[@CR14]\]. The study's inclusion criteria make it unlikely that participants were representative of MSM and transwomen in Lima, Peru.

Conclusions {#Sec12}
===========

We successfully recruited a cohort of MSM and transwomen with a high prevalence of recently acquired syphilis infection in Lima, Peru. Recently acquired syphilis infection was associated with socio-demographic characteristics, sexual risk behavior, and sexually transmitted co-infections. Because HIV transmission and acquisition is associated with recently acquired syphilis infection, public health strategies need to be updated in Peru to recommend routine syphilis screening in HIV care for MSM and transwomen.

ART

:   Antiretroviral therapy

CI

:   Confidence interval

CT

:   *Chlamydia trachomatis*

HIV

:   Human immunodeficiency virus

MSM

:   Men who have sex with men

NG

:   *Neisseria gonorrheae*

PR

:   Prevalence ratio

RPR

:   Rapid plasma reagin

STI

:   Sexually transmitted infection

TPPA

:   *Treponema Pallidum* Particle Agglutination

Transwomen

:   Male-to-female transgender women

VDRL

:   Venereal Disease Research Laboratory

The authors acknowledge the staff at Alberto Barton Health Center and Epicentro for their assistance in the study and the study participants. The authors thank Hologic, Inc. (San Diego, USA) for donated *Chlamydia trachomatis* and *Neisseria gonorrhoeae* testing supplies. The authors thank Ms. Jo Gerrard of the University of California, Riverside, for editorial assistance.

Funding {#FPar1}
=======

This study was funded by the National Institute of Allergy and Infectious Diseases (1R01AI099727--01: PI Caceres). JDK acknowledges funding from NIH P30MH058107 (The Center for HIV Identification, Prevention, and Treatment Services) and NIH/NIAID AI028697 (UCLA Center for AIDS Research).

Availability of data and materials {#FPar2}
==================================

Data and materials (biological samples) of the present study are available for review under the permissions of Universidad Peruana Cayetano Heredia and the University of California, Los Angeles. De-identified data are available from the corresponding author on reasonable request.

Authors' contributions {#FPar3}
======================

NK, HP, and KAK drafted manuscript, analyzed data, and interpreted results. DLJD, CCB, BB, and JDK edited manuscript and helped with data interpretation. SRL, SKV, and GMC made substantial contributions to data acquisition and draft revision. CFC and JDK designed the study. All authors read and approved the final manuscript.

Competing interests {#FPar4}
===================

The authors declare that they have no competing interests.

Consent for publication {#FPar5}
=======================

Not applicable.

Ethics approval and consent to participate {#FPar6}
==========================================

The Institutional Review Board at Universidad Peruana Cayetano Heredia and Alberto Barton Health Center provided ethical approval and oversight of the study: The reference number is SIDISI 59996. The University of California Los Angeles institutional review board determined that analysis of de-identified data was exempt from human subjects\' considerations. All participants were informed of study procedures, their ability to withdraw from the study at any time, and provided written consent.

Publisher's Note {#FPar7}
================

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
